Bank of New York Mellon’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
106,563
+2,904
| +3% | +$37.8K | ﹤0.01% | 2923 |
|
|
2025
Q1 | $2.62M | Buy |
103,659
+777
| +0.8% | +$19.6K | ﹤0.01% | 2551 |
|
|
2024
Q4 | $3.54M | Buy |
102,882
+9,385
| +10% | +$323K | ﹤0.01% | 2468 |
|
|
2024
Q3 | $4.62M | Sell |
93,497
-25,996
| -22% | -$1.28M | ﹤0.01% | 2327 |
|
|
2024
Q2 | $7.19M | Buy |
119,493
+17,368
| +17% | +$1.05M | ﹤0.01% | 2141 |
|
|
2024
Q1 | $5.27M | Sell |
102,125
-10,535
| -9% | -$543K | ﹤0.01% | 2300 |
|
|
2023
Q4 | $4.54M | Buy |
112,660
+6,457
| +6% | +$260K | ﹤0.01% | 2417 |
|
|
2023
Q3 | $2.96M | Buy |
106,203
+3,132
| +3% | +$87.4K | ﹤0.01% | 2585 |
|
|
2023
Q2 | $2.97M | Buy |
103,071
+37,413
| +57% | +$1.08M | ﹤0.01% | 2611 |
|
|
2023
Q1 | $1.1M | Buy |
65,658
+8,906
| +16% | +$149K | ﹤0.01% | 3095 |
|
|
2022
Q4 | $719K | Sell |
56,752
-136
| -0.2% | -$1.72K | ﹤0.01% | 3353 |
|
|
2022
Q3 | $683K | Buy |
56,888
+5,614
| +11% | +$67.4K | ﹤0.01% | 3392 |
|
|
2022
Q2 | $722K | Buy |
51,274
+12,611
| +33% | +$178K | ﹤0.01% | 3363 |
|
|
2022
Q1 | $479K | Buy |
38,663
+21,385
| +124% | +$265K | ﹤0.01% | 3731 |
|
|
2021
Q4 | $195K | Buy |
17,278
+2,065
| +14% | +$23.3K | ﹤0.01% | 4279 |
|
|
2021
Q3 | $193K | Buy |
+15,213
| New | +$193K | ﹤0.01% | 4218 |
|